Several types of cancer can cause hair loss through the disease itself, independent of chemotherapy, radiation, or any other treatment. The mechanisms vary widely: a tumor can physically invade the scalp and destroy hair follicles, a blood cancer can target follicles from within, a hormone-secreting tumor can flood the body with androgens, or a cancer’s byproducts can deposit in the skin and choke off hair growth. These scenarios are uncommon enough that doctors sometimes miss the connection entirely, treating the hair loss as a routine dermatological problem while the underlying malignancy goes unrecognized.
When Cancer Spreads to the Scalp
The most direct way a cancer causes hair loss is by metastasizing to the scalp. This condition has a formal name: alopecia neoplastica. It occurs when cells from an internal malignancy travel through the bloodstream or lymphatic system, lodge in the scalp’s soft tissue, and physically crowd out or destroy hair follicles.1PubMed. Cutaneous metastasis of breast carcinoma presenting as alopecia neoplastica The result is one or more patches of baldness that can look eerily similar to alopecia areata, the autoimmune condition that causes round, smooth bald spots.2JAMA. Alopecia Neoplastica: Hair Loss Resembling Alopecia Areata Caused by Metastatic Breast Cancer
Breast cancer is the most frequently reported source. Case after case in the medical literature describes women with breast cancer developing small, round bald patches on the scalp that turn out, on biopsy, to be metastatic deposits. A systematic review of alopecia neoplastica from visceral tumors confirmed that internal malignancies spreading to the scalp, while rare, represent a distinct and clinically important form of cutaneous metastasis.3PubMed. Alopecia neoplastica as a sign of visceral malignancies: a systematic review Other cancers reported to cause alopecia neoplastica include lung, kidney, and gastrointestinal cancers, though breast cancer dominates the published cases.
The hair loss itself can be scarring or non-scarring, depending on how deeply the tumor infiltrates the tissue. In some cases the skin looks normal apart from the missing hair. In others, the affected area feels firm or slightly discolored when touched, a subtle clue that something more than ordinary baldness is going on.
Why It Gets Misdiagnosed So Often
The resemblance between alopecia neoplastica and common benign conditions creates a real diagnostic trap. In one review of published cases of primary alopecia neoplastica, roughly a quarter of patients were initially misdiagnosed and treated for a non-cancerous form of hair loss, and more than a third of lesions had been present for years or for an unknown length of time before the correct diagnosis was made.4PubMed Central. Primary Alopecia Neoplastica: A Novel Case Report and Literature Review One case report describes a 43-year-old woman with lobular breast cancer who developed round bald patches on her scalp three years after her initial cancer diagnosis and was told by a dermatologist that she had alopecia areata.5PubMed Central. Secondary Alopecia Neoplastica Mimicking Alopecia Areata following Breast Cancer
The lesson for anyone with a history of cancer who develops unexplained patchy hair loss is straightforward: mention the cancer history to whatever dermatologist you see. A scalp biopsy can settle the question quickly. Specialized trichoscopy (a close-up examination of the scalp surface) can also reveal clues. In one breast cancer patient with scalp metastases, trichoscopy showed peripheral black dots and an unusual vascular pattern that pointed toward malignancy rather than autoimmune hair loss.6PubMed Central. Trichoscopy of Scalp Metastases These are findings a trained eye can spot before a biopsy is even performed.
Lymphomas That Target Hair Follicles
A group of blood cancers can cause hair loss by directly invading hair follicles rather than spreading to the scalp from a distant organ. The best-known example is folliculotropic mycosis fungoides, a subtype of cutaneous T-cell lymphoma. In this disease, cancerous immune cells have a particular affinity for hair follicle structures, infiltrating the follicular epithelium and disrupting normal hair growth.7PubMed. Folliculotropic mycosis fungoides: clinicopathological features and outcome in a series of 20 cases The neoplastic cells spread through the follicle, into sebaceous glands, and into sweat glands, essentially colonizing the structures that support hair.8PubMed Central. Cicatricial Alopecia Related to Folliculotropic Mycosis Fungoides
The hair loss from folliculotropic mycosis fungoides can be permanent. When the cancerous cells destroy the follicle architecture completely, the result is cicatricial (scarring) alopecia, where the follicle is replaced by scar tissue and cannot regrow hair even if the cancer is treated successfully. Patients often notice patches of thinning or complete hair loss on the scalp, sometimes accompanied by small bumps, redness, or itching that can look like a stubborn skin condition rather than cancer.
A closely related phenomenon is follicular mucinosis, in which mucin (a thick, gel-like substance) accumulates inside hair follicles and sebaceous glands. In adults, this condition is frequently secondary to cutaneous T-cell lymphoma, especially folliculotropic mycosis fungoides.9Skin Appendage Disorders. Extensive Alopecia Mucinosa and Response to Brentuximab Vedotin: A Case Report The mucin deposits physically disrupt the follicle, and the resulting alopecia can be irreversible. Two distinct patterns have been recognized since the 1950s: one that appears in younger people without any associated malignancy, and another that shows up in older adults in connection with lymphoma.10JAMA Dermatology. Follicular Mucinosis: A Critical Reappraisal of Clinicopathologic Features and Association With Mycosis Fungoides and Sézary Syndrome When an older patient develops follicular mucinosis, the possibility of an underlying lymphoma should be investigated.
Skin Cancers That Start on the Scalp
Primary malignancies arising directly on the scalp can also destroy hair follicles and produce bald patches. These are not metastases from elsewhere; the cancer originates in the scalp skin itself. Angiosarcoma, an aggressive cancer of blood vessel walls, is one example. A case report described an 83-year-old woman who presented with six months of hair loss and painless bruising on her forehead and scalp. Biopsy revealed angiosarcoma, with the tumor causing both miniaturization of hair follicles and scarring.11PubMed. Cutaneous angiosarcoma of the face and scalp presenting as alopecia Scalp angiosarcoma is notoriously difficult to recognize early because its initial appearance can be subtle, sometimes resembling a bruise or a mild skin change rather than a malignancy.
Morpheaform basal cell carcinoma is another primary skin cancer that can mimic hair loss conditions. This variant of basal cell carcinoma grows in a flat, scar-like pattern rather than forming an obvious bump or nodule. On the scalp, it can look remarkably like scarring alopecia, with the cancer slowly infiltrating the dermis and destroying follicles as it spreads. The clinical features are so subtle that delayed recognition is common, and by the time the diagnosis is made the tumor may have caused extensive local destruction.12PubMed Central. Giant Morpheaform Basal Cell Carcinoma Mimicking Scarring Alopecia: Exception Prone to Neglect
These scalp-origin cancers are rare, but they underline a broader principle: any area of hair loss on the scalp that does not respond to standard treatments, feels different in texture from surrounding skin, or progresses in an unusual pattern deserves a biopsy. Dermatologists are trained to think of these possibilities, but in practice, a scar-like patch of baldness on an elderly patient’s head is easy to write off as age-related thinning.
Hormone-Secreting Tumors
Some tumors cause hair loss not by touching the scalp at all but by dumping hormones into the bloodstream. The clearest example involves androgen-secreting ovarian tumors. These rare neoplasms produce testosterone at levels far above normal for women, triggering a cluster of masculinizing symptoms: rapid hair thinning in a male pattern, new facial hair growth, voice deepening, and other signs of virilization.13PubMed Central. Hyperandrogenism in a Postmenopausal Woman Secondary to Testosterone Secreting Ovarian Stromal Tumor with Acoustic Schwannoma
The hair loss in these cases follows the same pattern as ordinary androgenetic alopecia, thinning at the temples and crown, because the mechanism is the same: excess androgens shrinking hair follicles. The difference is that it happens rapidly and severely. In one case, a 42-year-old woman developed frontal hair loss, coarse facial hair, and voice changes, with testosterone levels measured at more than fifteen times the upper limit of normal for women. The cause turned out to be a Leydig cell tumor of the ovary that was too small to appear on standard imaging.14AACE Clinical Case Reports. Severe Hyperandrogenism in A Premenopausal Woman With An Imaging-Negative Leydig Cell Tumor The fact that the tumor was invisible on imaging is clinically important: a normal scan does not rule out a hormone-producing tumor if the blood tests point in that direction.
Adrenal tumors can produce a similar picture by secreting excess cortisol or androgens. Cushing’s disease, most often caused by a small pituitary tumor that drives overproduction of cortisol, can present with hair loss as a prominent symptom. One case report noted that hair loss was actually the chief complaint that brought the patient to medical attention, even though it is rarely the presenting symptom of Cushing’s disease.15PubMed Central. A Case Report of Cushing’s Disease Presenting as Hair Loss The cortisol excess alters the hormonal environment enough to push susceptible follicles into thinning.
The practical takeaway here is that sudden or severe androgenetic-pattern hair loss in a woman, especially when accompanied by other hormonal symptoms like menstrual changes, acne, or voice changes, warrants a hormonal workup. Most cases will turn out to be polycystic ovary syndrome or another benign cause, but the rare hormone-secreting tumor has to be excluded.
Systemic Disease and Protein Deposits
Multiple myeloma, a cancer of plasma cells in the bone marrow, can lead to hair loss through an indirect but still disease-driven route. Some myeloma patients develop systemic amyloidosis, a condition in which misfolded protein fragments produced by the cancer deposit in tissues throughout the body, including the skin. When amyloid infiltrates the scalp, it can disrupt hair follicle function and cause dramatic hair loss. Published reports have documented cases of complete body hair loss (alopecia universalis) from myeloma-associated amyloidosis. In one case, a 68-year-old woman presented with total hair loss along with kidney failure, and was found to have multiple myeloma with widespread amyloid deposits.16PubMed Central. Oligosecretory Myeloma With Amyloidosis and Alopecia
This is not treatment-related hair loss. The amyloid protein is a direct product of the malignant plasma cells, and the hair loss it causes is a consequence of the cancer’s biology rather than any medication. Only about sixteen cases of alopecia from systemic amyloidosis had been reported as of that publication, making it genuinely rare, but its existence illustrates how cancer can damage hair through mechanisms that have nothing to do with chemotherapy.
How the Tumor Itself Damages Follicles
The biological mechanisms by which tumors damage hair follicles vary depending on the cancer type, but a few patterns recur. Physical displacement is the most intuitive: metastatic cells or a primary tumor literally crowd out the follicle, compressing it, cutting off its blood supply, or replacing the tissue it needs to function. This is what happens in alopecia neoplastica from breast cancer metastases and in scalp angiosarcoma.
Follicular invasion works differently. In folliculotropic mycosis fungoides, the cancer cells are attracted specifically to follicular structures and infiltrate them from within. The destruction is biological rather than mechanical: the malignant lymphocytes disrupt the delicate signaling environment inside the follicle that hair growth depends on. Growth factors like TGF-beta1, which normally play a role in pushing hair follicles from their growth phase into their resting phase, can be dysregulated in the presence of tumor cells. In mouse studies, TGF-beta1 injected into the skin triggered premature follicle regression, reduced the number of dividing follicle cells, and increased cell death within the follicle.17FASEB Journal. Control of murine hair follicle regression (catagen) by TGF-beta1 in vivo Tumors that produce or stimulate such signals in the local tissue environment could push follicles into dormancy or death.
Hormonal disruption, as with androgen-secreting tumors, represents yet another mechanism. The follicle is not being physically destroyed or invaded; it is responding to an abnormal hormonal signal the same way it would in any case of excess androgens. The hair miniaturizes gradually, producing thinner and shorter strands until the follicle essentially gives up. Whether this process is reversible depends on how long the excess hormone exposure lasts and how far the follicular miniaturization has progressed before the tumor is removed.
What Happens to Hair After the Cancer Is Treated
The reversibility of cancer-caused hair loss depends entirely on the mechanism. When metastatic deposits are surgically removed or destroyed by treatment, hair may regrow if the follicle structures were not permanently damaged. Surgical reconstruction of scalp defects after tumor removal has advanced considerably. Techniques like the O-Z flap can repair scalp wounds with good cosmetic results, including hair growth in the reconstructed area.18Journal of Craniofacial Surgery. Use of the O-Z Flap to Repair Scalp Defects After Cancer Tumor Resection However, scar tissue from healing typically does not regrow hair. In cases requiring extensive resection of malignant scalp tumors, scarring in the flap-healed areas left permanent bald patches, though surrounding hair often concealed them adequately.19PubMed Central. Maximal resection for malignant scalp tumors: is it valuable for long-term follow-up?
For hormone-secreting tumors, removing the tumor typically stops the excess hormone production and halts further hair loss. Some degree of regrowth often follows, though it can take months and may not fully restore the original density, particularly if the follicles had been miniaturized for a long time. For scarring alopecia caused by folliculotropic mycosis fungoides or by amyloid deposits that have destroyed follicle architecture, regrowth is unlikely. The follicle has been permanently replaced by scar tissue or amyloid, and no treatment can regenerate it.
Paraneoplastic Alopecia in Animals
An interesting parallel exists in veterinary medicine. Cats can develop a condition called feline paraneoplastic alopecia, in which an internal cancer, often of the pancreas or liver, causes dramatic symmetrical hair loss and shiny skin without the cancer directly touching the skin at all. The mechanism is thought to involve substances released by the tumor that interfere with normal hair growth at a distance. This has been documented in association with pancreatic carcinoma, bile duct carcinoma, hepatocellular carcinoma, and in at least one case, colon carcinoma.20PubMed Central. Feline paraneoplastic alopecia associated with metastasising intestinal carcinoma
True paraneoplastic alopecia in humans is far less clearly established. Occasional case reports describe hair loss in cancer patients that does not fit neatly into any of the categories above and may represent a paraneoplastic phenomenon, but the evidence base is thin. The feline version is better characterized and serves as a reminder that cancers can affect distant tissues through circulating factors rather than physical contact. Whether a robust human equivalent exists, beyond the hormonal and amyloid-mediated pathways already discussed, remains an open question in dermatology.
Red Flags Worth Knowing
Most hair loss is not cancer. The vast majority of people losing their hair are dealing with androgenetic alopecia, telogen effluvium from stress or illness, alopecia areata, or another benign cause. But a few features should prompt further investigation:
- History of cancer: Any new or unusual hair loss in someone with a current or prior cancer diagnosis, especially breast cancer, should be evaluated with the possibility of scalp metastasis in mind.
- Firmness or skin changes: Bald patches where the skin feels hard, thickened, or discolored may indicate underlying tumor infiltration rather than autoimmune hair loss.
- Rapid virilization in women: Sudden onset of male-pattern hair loss combined with facial hair, acne, voice changes, or menstrual irregularities suggests a hormonal cause that needs investigation.
- Treatment resistance: Hair loss that does not respond at all to standard treatments for the presumed diagnosis deserves a biopsy to rule out malignancy.
- Associated systemic symptoms: Hair loss accompanied by unexplained weight loss, kidney problems, fatigue, or skin changes elsewhere on the body raises the stakes for a thorough workup.
None of these features guarantee cancer, but each one lowers the threshold at which a biopsy becomes worth doing. The consistent theme across the published case reports is that delays in diagnosis happen when clinicians treat the hair loss as a standalone problem rather than considering it as a potential sign of something deeper.